Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ilika plc ( (GB:IKA) ) just unveiled an update.
Ilika plc, the UK solid-state battery developer, has completed its first commercial delivery of Stereax electrodes to Cirtec Medical for use in Stereax M300 batteries. The shipment marks the first revenue-generating order under their electrode supply arrangement, positioning Ilika’s UK facility as a qualified supplier into Cirtec’s manufacturing workflows.
The electrodes will support validation and customer sampling of M300 batteries across a broad range of active implantable medical device applications, from sensors and neurostimulators to orthopaedic and ophthalmology devices. Management at both companies highlighted the evolution from technical collaboration to an operational partnership, signalling potential for increased supply volumes as customer demand for miniaturised implantable power solutions grows.
The most recent analyst rating on (GB:IKA) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.
Spark’s Take on GB:IKA Stock
According to Spark, TipRanks’ AI Analyst, GB:IKA is a Neutral.
The score is held down primarily by weak financial performance (sharp revenue decline, ongoing losses, and negative operating/free cash flow) and a bearish-to-soft technical setup (below major moving averages with negative MACD). Valuation is limited by negative earnings. These are partially offset by earnings-call evidence of operational and early commercial progress (customer deliveries, purchase orders, and prototype milestones), though cash burn and long licensing timelines remain key risks.
To see Spark’s full report on GB:IKA stock, click here.
More about Ilika plc
Ilika plc is a UK-based specialist in solid-state battery technology for electric vehicles, medical devices and consumer appliances, developing next-generation solutions that are smaller, lighter and safer than conventional batteries. The company markets two main product lines: Stereax miniature batteries for medical implants, industrial sensors and IoT uses, and Goliath large-format cells for electric vehicles and cordless appliances, which it commercialises through a licensing-led model with OEMs and manufacturing partners.
Average Trading Volume: 290,471
Technical Sentiment Signal: Sell
Current Market Cap: £54.25M
For an in-depth examination of IKA stock, go to TipRanks’ Overview page.